Bernadette Gallagher

Senior Research Nurse

Research Interests:
Emergency medicine, Public Health, Global Health

Qualifications:
Emergency Nurse Practitioner Qualification, BSc Specialist Nursing – Adult, Advanced Emergency Care in A&E Certification, ENB 997/998 Teaching and Assessing, Registered General Nurse Training

Twitter:
@emerge_research

I joined the EMERGE team in 2015 having previously has a range of experience wearing different hats ranging from emergency nurse, ENP, research nurse, trial co-ordinator, trial monitor and trial manager (no I am not 100 years old). This opportunity enabled me to finally put my emergency nursing and research background together.

My emergency department experience began in Glasgow and I went on to work in London and Australia. In 2010, I began my research career as a research nurse in the commercial world working in Phase I-IV and experimental clinical research in a variety of therapeutic areas.

At the moment I am studying for the Masters in Public Health, part-time at Edinburgh University. Although hard work, it is very interesting and relevant to my role in EMERGE and my future career.

Trials

The study with PP100-01 in combination with NAC is designed to determine safety and tolerability of PP100-01 when co-administered with NAC as compared to the 12-hr NAC treatment regime for patients that come to the hospital after an overdose of paracetamol/acetaminophen.

The POP Trial

A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose

Evaluating the kinetics of cardiac biomarkers after ST-segment Elevation myocardial infarction

Intervention
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.

RAMPP trial

RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax

A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage. E-FIT1 Study

E-FIT1 Trial

A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage. E-FIT 1 Study

Assessing tranexamic acid after hyperacute spontaneous intracerebral haemorrhage.